Prognostic role of progesterone receptor (PR) expression by immunohistochemistry (IHC) in relation to Oncotype recurrence scores (RS).
dc.contributor.author | Kapucuoglu, Nilgun | |
dc.contributor.author | Uras, Cihan | |
dc.contributor.author | Boler, Deniz | |
dc.contributor.author | Saglican, Yesim | |
dc.contributor.author | Ince, Umit | |
dc.contributor.author | Basaran, Gul | |
dc.contributor.author | Korkmaz, Taner | |
dc.contributor.author | Kara, Halil | |
dc.date.accessioned | 2021-03-05T13:10:14Z | |
dc.date.available | 2021-03-05T13:10:14Z | |
dc.identifier.citation | Basaran G., Korkmaz T., Kara H., Boler D., Kapucuoglu N., Uras C., Saglican Y., Ince U., "Prognostic role of progesterone receptor (PR) expression by immunohistochemistry (IHC) in relation to Oncotype recurrence scores (RS).", Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_b0e711e9-b878-49a6-94a0-9fb84f56b925 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/117882 | |
dc.identifier.uri | https://doi.org/10.1200/jco.2015.33.15_suppl.e11589 | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Prognostic role of progesterone receptor (PR) expression by immunohistochemistry (IHC) in relation to Oncotype recurrence scores (RS). | |
dc.type | Bildiri | |
dc.contributor.department | , , | |
dc.identifier.volume | 33 | |
dc.contributor.firstauthorID | 146642 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]